Karela

Himalaya Wellbeing Unadulterated Spices Karela Metabolic Health Tablets include unpleasant melon (karela), a conventional Ayurvedic spice known for its glucose-adjusting properties. Karela helps in improving the digestive process, useful in healthy weight management, aids in regulating blood sugar level.

Product dosage: 250 mg
Package (num)	Per pill	Price	Buy
180	0.41 $	73.71 $ (0%)	🛒 Add to cart
360	0.26 $ Best per pill	147.42 $ 92.43 $ (37%)	🛒 Add to cart

Karela, derived from Momordica charantia and commonly known as bitter melon, is a scientifically-formulated dietary supplement designed to support healthy blood glucose levels and promote metabolic wellness. This product leverages centuries of traditional use with modern extraction techniques to deliver a potent, standardized concentration of active compounds, including charantin, polypeptide-p, and vicine. It is engineered for individuals seeking a natural, evidence-based approach to complement their health regimen, particularly for maintaining insulin sensitivity and pancreatic beta-cell function. Expertly crafted under stringent quality controls, each capsule ensures purity, potency, and bioavailability for optimal therapeutic outcomes.

Features

• Standardized extract of Momordica charantia (bitter melon) for consistent bioactive compound delivery
• High concentration of charantin (≥2.5%) and polypeptide-p, key agents in glucose metabolism
• Vegan, gluten-free, and non-GMO formulation with no artificial binders or fillers
• Produced in a cGMP-certified facility, ensuring pharmaceutical-grade quality and safety
• Third-party tested for heavy metals, pesticides, and microbial contaminants
• Delayed-release capsule technology to enhance absorption in the intestinal tract

Benefits

• Supports healthy fasting and postprandial blood glucose levels through enhanced cellular glucose uptake
• Promotes insulin secretion and sensitivity, aiding in the management of metabolic syndrome parameters
• Provides antioxidant protection against oxidative stress commonly associated with hyperglycemia
• Assists in lipid metabolism, contributing to improved cardiovascular health markers
• Helps maintain healthy pancreatic beta-cell function and integrity
• Supports weight management efforts by modulating appetite and improving metabolic efficiency

Common use

Karela is commonly utilized as an adjunctive therapy in the management of type 2 diabetes mellitus and prediabetic conditions. It is often incorporated into holistic health regimens aimed at improving glycemic control, reducing hemoglobin A1c levels, and mitigating insulin resistance. Healthcare providers may recommend it for patients seeking complementary support alongside conventional antidiabetic medications, lifestyle modifications, or dietary interventions. It is also used by individuals focusing on preventive metabolic health, including those with a family history of diabetes or metabolic disorders.

Dosage and direction

The recommended dosage for Karela is one 500 mg capsule taken twice daily, approximately 30 minutes before meals, with a full glass of water. For optimal absorption and to minimize gastrointestinal discomfort, consistency in timing is advised. Dosage may be adjusted based on individual tolerance, health status, and under the guidance of a healthcare professional. It is not recommended to exceed two capsules per day unless directed by a physician. Allow 4–6 weeks of consistent use to observe significant therapeutic effects; long-term use may be necessary for sustained benefits.

Precautions

• Consult a healthcare provider before use if you are pregnant, breastfeeding, or attempting conception, as safety data in these populations is limited.
• Monitor blood glucose levels regularly when initiating supplementation to avoid hypoglycemia, especially if using concomitant glucose-lowering agents.
• Discontinue use at least two weeks prior to scheduled surgery due to potential effects on blood sugar regulation.
• Use with caution in individuals with known gastrointestinal sensitivities, as bitter melon may cause mild digestive upset.
• Not intended for the treatment of type 1 diabetes or diabetic ketoacidosis; use only under medical supervision in such cases.
• Keep out of reach of children and store in a cool, dry place to preserve stability and efficacy.

Contraindications

Karela is contraindicated in individuals with a known hypersensitivity to Momordica charantia or any excipients in the formulation. It should not be used by patients with severe hepatic or renal impairment unless approved by a qualified healthcare practitioner. Contraindicated in those with hypoglycemic disorders or a history of severe hypoglycemia. Avoid use in children under the age of 18 due to insufficient safety and efficacy data. Not recommended for individuals with G6PD deficiency due to the potential risk of hemolytic anemia associated with vicine content.

Possible side effect

While generally well-tolerated, some users may experience mild and transient side effects, including gastrointestinal discomfort, nausea, or diarrhea. Hypoglycemia may occur, particularly when combined with other antidiabetic therapies, manifesting as dizziness, sweating, or palpitations. Allergic reactions, though rare, may include rash, itching, or respiratory symptoms. Cases of headache and abdominal cramping have been reported anecdotally. Discontinue use and seek medical attention if severe or persistent adverse effects occur.

Drug interaction

Karela may potentiate the effects of antidiabetic medications (e.g., metformin, sulfonylureas, insulin), increasing the risk of hypoglycemia; dose adjustment of concomitant drugs may be necessary. It may interact with drugs metabolized by CYP450 enzymes, though clinical significance is uncertain. Concurrent use with other hypoglycemic agents or supplements (e.g., cinnamon, fenugreek) should be monitored closely. Theoretical interactions exist with anticoagulants due to mild antiplatelet activity; exercise caution if using warfarin or aspirin. Always inform your healthcare provider of all medications and supplements in use.

Missed dose

If a dose is missed, take it as soon as remembered unless it is nearly time for the next scheduled dose. Do not double the dose to make up for a missed one. Maintaining a consistent dosing schedule is important for stable glycemic support, but occasional missed doses are unlikely to cause significant disruption. Set reminders or incorporate dosing into daily routines to improve adherence.

Overdose

Symptoms of overdose may include severe hypoglycemia, manifested by confusion, tremors, sweating, loss of consciousness, or seizures. Gastrointestinal distress, such as vomiting or diarrhea, may also occur. In case of suspected overdose, seek immediate medical attention. Supportive care, including glucose administration and symptomatic treatment, may be necessary. Do not induce vomiting unless directed by a poison control center or healthcare provider.

Storage

Store Karela in a cool, dry place away from direct sunlight, moisture, and heat sources. Keep the bottle tightly closed and stored at room temperature (15–30°C or 59–86°F). Do not refrigerate or freeze. Discard any product that shows signs of tampering, discoloration, or unusual odor. Keep out of reach of children and pets to prevent accidental ingestion.

Disclaimer

This product is not intended to diagnose, treat, cure, or prevent any disease. The information provided is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider before starting any new supplement, especially if you have a pre-existing medical condition or are taking other medications. Individual results may vary, and the efficacy of this product has not been evaluated by the Food and Drug Administration.

Reviews

Clinical studies and user testimonials frequently report improved glycemic control and enhanced well-being with regular use of Karela supplementation. In a 12-week randomized trial, participants using standardized bitter melon extract showed significant reductions in fasting blood glucose and HbA1c levels compared to placebo. Users often note increased energy, reduced sugar cravings, and better management of post-meal glucose spikes. Some report mild initial gastrointestinal adaptation, which typically resolves within the first week. Overall, satisfaction is high among those seeking a natural adjunct to lifestyle modifications for metabolic health.